002319SZSE

2025 Annual Independent Director's Report (He Suying)

Letong Co., Ltd.·

✨ AI Summary

This report details He Suying's performance as an independent director for Zhuhai Letong Chemical Co., Ltd. during 2025. It covers attendance at board and shareholder meetings, participation in committees, and oversight of financial reporting and related-party transactions. The report confirms compliance with regulations and affirms the protection of shareholder interests.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_documentSign In to Upgrade

Independent Director's Report for 2025

(He Suying)

To the Shareholders and Shareholder Representatives:

As an independent director of Zhuhai Letong Chemical Co., Ltd. (hereinafter referred to as the "Company"), I have strictly adhered to the requirements of relevant laws, regulations, and rules such as the "Company Law," "Securities Law," "Guiding Opinions on Establishing an Independent Director System for Listed Companies," "Articles of Association," "Several Provisions on Strengthening the Protection of the Rights and Interests of Publicly Issued Shares," and the "Independent Director Work System." I have fully exercised my role as an independent director, diligently performed my duties, actively participated in company meetings, conscientiously reviewed all proposals submitted to the board of directors, and offered objective, independent, and prudent opinions, thereby effectively safeguarding the interests of the Company and its shareholders, especially minority shareholders. This report outlines my performance of independent director duties for 2025.

I. Basic Information of Independent Director

I, He Suying, born in 1966, am a Chinese national with no permanent overseas residency and hold a Master's degree. I have previously served as a director of Shenzhen SEG Electronics Co., Ltd., an independent director of Shenzhen Kaiming Sen Environmental Protection Technology Co., Ltd., an independent director of Dasheng Times Culture Investment Co., Ltd., and an independent director of Sinopharm Group Co., Ltd. I am currently the executive director of Shenzhen Kaibao Asset Management Co., Ltd. I served as an independent director of the Company from August 2019 to August 2025.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…